Welcome Remarks

On behalf of the organizing committee, I am delighted to invite you to our 2nd Kuwait Hematology Conference (KHC 2024), to be held from 28th - 30th November, 2024. The organizing and scientific committee are proudly working very hard to bring our attendees state of the art learning experience in the region.

The conference aims to bring together hematology expertise to provide high-quality educational content and provide a platform for sharing the latest hematology clinical trial data, helping to support the implementation of best clinical practice.

KHC 2024 is expected to attract over 500 healthcare professionals in this inaugural edition from across the region to exchange and share their experiences. The comprehensive scientific program will add value to health care professionals interested in improving their professional practice and patient care quality.

We look forward to welcoming you to KHC 2024!

Dr. Ahmad Alhuraji

President

Kuwait Hematology Association

Kuwait

Who Should Attend?

  • Hematologists
  • Hematopathologists
  • Oncologists
  • General Practitioners
  • Nurses
  • Residents
  • Medical Students
  • Academics
  • Allied Health

Important Dates

Sep 27

Early Bird Registration Closes

Sep 30

Abstract Submission Closes

Nov 7

CME Announced

Nov 28

KHC 2024 Goes Live!

Program

We warmly welcome you to the scientific program of 2nd Kuwait Hematology Conference 2024, this meeting of minds promises to be a milestone in the realm of Hematology.

The program has been meticulously designed to serve as a platform for sharing the latest breakthroughs and insights in hematology. It encompasses a variety of engaging sessions that delve into the most advanced areas in hematological sciences, promising a rich and enlightening experience.

We invite you to join us on this journey of exploration and discovery, as we collectively strive to enhance our understanding and treatment of hematology conditions.

KHC 2024 is an opportunity to meet and network with some of the world’s most renowned experts.​ Engage with global key opinion leaders in clinical practice as well as leading and emerging scientists who are advancing research in hematology​